Mouse and cell culture studies indicated an important role of intestinal SELENOP expression for the progression of adenomas to carcinoma, e.g. by modulating WNT signaling through LDL receptor-related proteins, i.e., members of the same family as the established SELENOP-specific uptake receptors [28,62]. This evidence concerns the gene SELENOP and carcinoma.